Timothy N. Perkins

1.2k citations

28 papers · 905 indexed · h-index 14

Pulmonary and Respiratory Medicine top 5%
Molecular Biology
Immunology
Clinical Biochemistry top 2%
Health, Toxicology and Mutagenesis top 10%

Co-authors: Tim D. Oury Elizabeth A. Oczypok Niki L. Reynaert Emiel F.�M. Wouters Brooke T. Mossman Paul Peeters Arti Shukla Roel P. F. Schins
Topics: Occupational and environmental lung diseases (10 papers)Neonatal Respiratory Health Research (6 papers)Respiratory viral infections research (5 papers)
Cited by: Clinical Biochemistry Pulmonary and Respiratory Medicine Immunology
Journals: Journal of Allergy and Clinical Immunology Human Molecular Genetics Frontiers in Immunology
Partner nations: United States Netherlands Australia

In The Last Decade

Timothy N. Perkins

28 papers receiving 897 citations

Peers

Countries citing papers authored by Timothy N. Perkins

Since Specialization

Citations

This map shows the geographic impact of Timothy N. Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy N. Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy N. Perkins more than expected).

Fields of papers citing papers by Timothy N. Perkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy N. Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy N. Perkins. The network helps show where Timothy N. Perkins may publish in the future.

Co-authorship network of co-authors of Timothy N. Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy N. Perkins. A scholar is included among the top collaborators of Timothy N. Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy N. Perkins. Timothy N. Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD 2023 ·Journal of Clinical Medicine ·Niki L. Reynaert,Lowie E.G.W. Vanfleteren,Timothy N. Perkins	18
2	Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams 2023 ·Frontiers in Immunology ·(unknown),Katherine M. Eichinger,(unknown),(unknown),(unknown),Mark A. Yondola,Timothy N. Perkins,Kerry M. Empey	4
3	RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice 2023 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),Kerry M. Empey,Tim D. Oury,Timothy N. Perkins	12
4	Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation 2022 ·Frontiers in Immunology ·Katherine M. Eichinger,(unknown),Timothy N. Perkins,Tim D. Oury,Nikolai Petrovsky,Christopher Marshall,Mark A. Yondola,Kerry M. Empey	7
5	Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice 2020 ·Vaccine ·(unknown),Katherine M. Eichinger,(unknown),Mark A. Yondola,Timothy N. Perkins,Kerry M. Empey	12
6	Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity 2020 ·Vaccine ·Katherine M. Eichinger,(unknown),(unknown),Timothy N. Perkins,Nikolai Petrovsky,Christopher Marshall,Mark A. Yondola,Kerry M. Empey	11
7	Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection 2020 ·Frontiers in Immunology ·Katherine M. Eichinger,(unknown),(unknown),(unknown),(unknown),Timothy N. Perkins,Tim D. Oury,Nikolai Petrovsky,Christopher Marshall,Mark A. Yondola,Kerry M. Empey	43
8	The receptor for advanced glycation end products is a critical mediator of type 2 cytokine signaling in the lungs 2019 ·Journal of Allergy and Clinical Immunology ·Timothy N. Perkins,Elizabeth A. Oczypok,(unknown),(unknown),Michael M. Myerburg,Tim D. Oury	38
9	RAGE‐dependent VCAM‐1 expression in the lung endothelium mediates IL‐33‐induced allergic airway inflammation 2018 ·Allergy ·Timothy N. Perkins,Elizabeth A. Oczypok,Pavle S. Milutinovic,(unknown),Tim D. Oury	28
10	Crystalline silica alters Sulfatase-1 expression in rat lungs which influences hyper-proliferative and fibrogenic effects in human lung epithelial cells 2018 ·Toxicology and Applied Pharmacology ·Timothy N. Perkins,Paul Peeters,Catrin Albrecht,Roel P. F. Schins,Mieke A. Dentener,Brooke T. Mossman,Emiel F.�M. Wouters,Niki L. Reynaert	10
11	Alveolar Epithelial Cell–Derived Mediators: Potential Direct Regulators of Large Airway and Vascular Responses 2017 ·American Journal of Respiratory Cell and Molecular Biology ·Elizabeth A. Oczypok,Timothy N. Perkins,Tim D. Oury	6
12	All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses 2017 ·Paediatric Respiratory Reviews ·Elizabeth A. Oczypok,Timothy N. Perkins,Tim D. Oury	185
13	Alteration of canonical and non-canonical WNT-signaling by crystalline silica in human lung epithelial cells 2016 ·Toxicology and Applied Pharmacology ·Timothy N. Perkins,Mieke A. Dentener,Frank Stassen,Gernot Rohde,Brooke T. Mossman,Emiel F.�M. Wouters,Niki L. Reynaert	19
14	Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas 2014 ·American Journal of Respiratory Cell and Molecular Biology ·Mutlay Sayan,Arti Shukla,Maximilian B. MacPherson,(unknown),Jedd Hillegass,Timothy N. Perkins,Joyce K. Thompson,Stacie L. Beuschel,(unknown),Brooke T. Mossman	10
15	Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs 2014 ·Particle and Fibre Toxicology ·Paul Peeters,(unknown),Timothy N. Perkins,Emiel F.�M. Wouters,Roel P. F. Schins,Paul J. A. Borm,W. Drommer,Niki L. Reynaert,Catrin Albrecht	103
16	Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells 2014 ·Human Molecular Genetics ·Timothy N. Perkins,Paul Peeters,Arti Shukla,Ingrid Arijs,Julie A. Dragon,Emiel F.�M. Wouters,Niki L. Reynaert,Brooke T. Mossman	21
17	Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells 2013 ·Particle and Fibre Toxicology ·Jedd Hillegass,(unknown),Maximilian B. MacPherson,(unknown),Mutlay Sayan,Joyce K. Thompson,(unknown),Timothy N. Perkins,Stacie L. Beuschel,(unknown),Harvey I. Pass,Chad Steele,Brooke T. Mossman,Arti Shukla	92
18	Silica induces NLRP3 inflammasome activation in human lung epithelial cells 2013 ·Particle and Fibre Toxicology ·Paul Peeters,Timothy N. Perkins,Emiel F.�M. Wouters,Brooke T. Mossman,Niki L. Reynaert	141
19	Differences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cells 2012 ·Particle and Fibre Toxicology ·Timothy N. Perkins,Arti Shukla,Paul Peeters,Jeremy L. Steinbacher,Christopher C. Landry,(unknown),Chad Steele,Niki L. Reynaert,Emiel F.�M. Wouters,Brooke T. Mossman	53
20	Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells 2010 ·Particle and Fibre Toxicology ·Jedd Hillegass,Arti Shukla,Maximilian B. MacPherson,(unknown),(unknown),Timothy N. Perkins,Albert van der Vliet,Pamela M. Vacek,Mickey E. Gunter,Brooke T. Mossman	22

About Timothy N. Perkins

Timothy N. Perkins is a scholar working on Clinical Biochemistry, Emergency Medical Services and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 905 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (10 papers), Neonatal Respiratory Health Research (6 papers) and Respiratory viral infections research (5 papers). The work is most often cited by research in Clinical Biochemistry (163 citations), Pulmonary and Respiratory Medicine (405 citations) and Immunology (214 citations). Timothy N. Perkins has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Tim D. Oury, Elizabeth A. Oczypok, Niki L. Reynaert, Emiel F.�M. Wouters, Brooke T. Mossman, Paul Peeters, Arti Shukla, Roel P. F. Schins, Catrin Albrecht and Chad Steele. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Human Molecular Genetics and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact